AJIC: American Journal of Infection Control
Volume 38, Issue 1 , Pages 78-80, February 2010

Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections

  • Cassandra Moran, DO

      Affiliations

    • Department of Pediatrics, Duke University School of Medicine, Durham, NC
    • ,
  • Chelsea A. Grussemeyer, BSPH

      Affiliations

    • Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC
    • ,
  • James R. Spalding, PharmD, MS

      Affiliations

    • Astellas Pharma US, Deerfield, IL
    • ,
  • Daniel K. Benjamin Jr., MD, MPH, PhD

      Affiliations

    • Department of Pediatrics, Duke University School of Medicine, Durham, NC
    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Shelby D. Reed, PhD

      Affiliations

    • Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC
    • Department of Medicine, Duke University School of Medicine, Durham, NC
    • Corresponding Author InformationAddress correspondence to Shelby D. Reed, PhD, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715.

published online 19 October 2009.

We compared costs, length of stay, and mortality between adults with Candida albicans and Candida glabrata bloodstream infections. Early evidence of C glabrata, as defined by a positive culture within 2 days of admission, was associated with higher costs ($56,026 vs $32,810; P = .04) and longer hospital stays (19.7 vs 14.5 days; P = .05) compared with early evidence of C albicans. Mortality was similar between the groups.

Key Words: Candida albicans, Candida glabrata, cross infection, health care costs, length of stay, mortality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0196-6553(09)00755-X

doi:10.1016/j.ajic.2009.06.014

AJIC: American Journal of Infection Control
Volume 38, Issue 1 , Pages 78-80, February 2010

Article Tools